Explore

Trendline Trendline
Atisama Therapeutics Progresses RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Progresses RB042 in Phase 1 Trial and Appoints New Board Chair

Atisama Therapeutics Progresses RB042 in Phase 1 Trial and Appoints New Board Chair
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments

Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments

Spruce Biosciences Reports Q1 2026 Financial Results and Strategic Developments
Trendline Trendline
17 Biopharma Companies Actively Hiring in California Amid Job Posting Decline

17 Biopharma Companies Actively Hiring in California Amid Job Posting Decline

17 Biopharma Companies Actively Hiring in California Amid Job Posting Decline
Trendline Trendline
Psyence BioMed Launches U.S. Initiative for Ibogaine Research and Manufacturing

Psyence BioMed Launches U.S. Initiative for Ibogaine Research and Manufacturing

Psyence BioMed Launches U.S. Initiative for Ibogaine Research and Manufacturing
Trendline Trendline
Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair
Trendline Trendline
Precision BioSciences Unveils Promising Preclinical Data for Duchenne Muscular Dystrophy Treatment

Precision BioSciences Unveils Promising Preclinical Data for Duchenne Muscular Dystrophy Treatment

Precision BioSciences Unveils Promising Preclinical Data for Duchenne Muscular Dystrophy Treatment
Trendline Trendline
Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates

Spruce Biosciences Reports Q1 2026 Financial Results and Corporate Updates
Trendline Trendline
Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations

Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations

Personalis to Engage with Investors at Upcoming Conferences to Highlight Genomic Innovations
Trendline Trendline
Biopharma Job Market Sees Growth Despite Continued Layoffs

Biopharma Job Market Sees Growth Despite Continued Layoffs

Biopharma Job Market Sees Growth Despite Continued Layoffs
Trendline Trendline
Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026

Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026

Inhibrx Reports Financial Results and Clinical Trial Updates for Q1 2026
Trendline Trendline
Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference

Sarepta Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
Trendline Trendline
Tevard Biosciences Unveils Promising Preclinical Data on Suppressor tRNA Therapy

Tevard Biosciences Unveils Promising Preclinical Data on Suppressor tRNA Therapy

Tevard Biosciences Unveils Promising Preclinical Data on Suppressor tRNA Therapy